TNFRSF9 Suppressed the Progression of Breast Cancer via the p38MAPK/PAX6 Signaling Pathway

Table 1

Association analysis of TNFRSF9 expression and the clinicopathological features in 30 breast cancer patients.

Characteristics	Case number	TNFRSF9 expression		p value
		Low (n = 20)	High (n = 10)
Number	30	20	10
Ages (years)				0.5921^a
≤55	19	12	7
>55	11	8	3
Tumor size				0.5839^a
≤2 cm	10	6	4
>2 cm	20	14	6
HR (estrogen receptor) status				0.6048^a
Negative	14	10	4
Positive	16	10	6
HER2 status				0.7945 ^a
Negative	17	11	6
Positive	13	9	4
Lymph node metastasis				0.0007 ^a
No	9	2	7
Yes	21	18	3
TNM stage				0.0016^a
I–II	12	4	8
III	18	16	2

^aTwo-sided chi-squared test.